The post INJ Price Prediction: Technical Recovery to $6.33 Before December Correction to $5.17 appeared on BitcoinEthereumNews.com. Iris Coleman Nov 22, 2025 17:59 INJ price prediction shows recovery to $6.33 within one week, followed by potential decline to $5.17 by December 21. Mixed analyst forecasts reflect current market uncertainty. INJ Price Prediction Summary • INJ short-term target (1 week): $6.33 (+16.4%) • Injective medium-term forecast (1 month): $5.17-$7.50 range• Key level to break for bullish continuation: $6.74 (20-day SMA) • Critical support if bearish: $5.19 (immediate support) Recent Injective Price Predictions from Analysts The latest INJ price prediction landscape reveals a divided analyst community. Blockchain.News maintains an optimistic stance with their Injective forecast targeting $6.33 in the short term, despite the recent 12.88% decline. Their medium-term projection extends to $7.50-$9.17, banking on the upcoming Altria upgrade as a catalyst. However, contrarian views emerge from CoinCheckup’s technical analysis, which suggests a bearish INJ price target of $5.17 by December 21, 2025. This creates an interesting dichotomy where short-term optimism meets medium-term pessimism. CoinMarketCap’s $9.17 prediction relies heavily on the Altria Mainnet Upgrade and potential ETF approvals, while Coinbase’s conservative long-term forecast of $7.14 by 2030 reflects a modest 5% annual growth expectation. The consensus reveals medium confidence levels across most predictions, indicating uncertainty in the current market environment for Injective. INJ Technical Analysis: Setting Up for Short-Term Recovery Current technical indicators paint a mixed but potentially recovering picture for our INJ price prediction. With INJ trading at $5.44, the token sits precariously close to its 52-week low of $5.44, suggesting we may have found a temporary floor. The RSI reading of 31.18 indicates oversold conditions without reaching extreme levels, providing room for a technical bounce. The MACD histogram at -0.0621 shows bearish momentum is weakening, though not yet reversed. Most compelling is INJ’s position within the Bollinger Bands at 0.0347,… The post INJ Price Prediction: Technical Recovery to $6.33 Before December Correction to $5.17 appeared on BitcoinEthereumNews.com. Iris Coleman Nov 22, 2025 17:59 INJ price prediction shows recovery to $6.33 within one week, followed by potential decline to $5.17 by December 21. Mixed analyst forecasts reflect current market uncertainty. INJ Price Prediction Summary • INJ short-term target (1 week): $6.33 (+16.4%) • Injective medium-term forecast (1 month): $5.17-$7.50 range• Key level to break for bullish continuation: $6.74 (20-day SMA) • Critical support if bearish: $5.19 (immediate support) Recent Injective Price Predictions from Analysts The latest INJ price prediction landscape reveals a divided analyst community. Blockchain.News maintains an optimistic stance with their Injective forecast targeting $6.33 in the short term, despite the recent 12.88% decline. Their medium-term projection extends to $7.50-$9.17, banking on the upcoming Altria upgrade as a catalyst. However, contrarian views emerge from CoinCheckup’s technical analysis, which suggests a bearish INJ price target of $5.17 by December 21, 2025. This creates an interesting dichotomy where short-term optimism meets medium-term pessimism. CoinMarketCap’s $9.17 prediction relies heavily on the Altria Mainnet Upgrade and potential ETF approvals, while Coinbase’s conservative long-term forecast of $7.14 by 2030 reflects a modest 5% annual growth expectation. The consensus reveals medium confidence levels across most predictions, indicating uncertainty in the current market environment for Injective. INJ Technical Analysis: Setting Up for Short-Term Recovery Current technical indicators paint a mixed but potentially recovering picture for our INJ price prediction. With INJ trading at $5.44, the token sits precariously close to its 52-week low of $5.44, suggesting we may have found a temporary floor. The RSI reading of 31.18 indicates oversold conditions without reaching extreme levels, providing room for a technical bounce. The MACD histogram at -0.0621 shows bearish momentum is weakening, though not yet reversed. Most compelling is INJ’s position within the Bollinger Bands at 0.0347,…

INJ Price Prediction: Technical Recovery to $6.33 Before December Correction to $5.17



Iris Coleman
Nov 22, 2025 17:59

INJ price prediction shows recovery to $6.33 within one week, followed by potential decline to $5.17 by December 21. Mixed analyst forecasts reflect current market uncertainty.

INJ Price Prediction Summary

• INJ short-term target (1 week): $6.33 (+16.4%)
• Injective medium-term forecast (1 month): $5.17-$7.50 range
• Key level to break for bullish continuation: $6.74 (20-day SMA)
• Critical support if bearish: $5.19 (immediate support)

Recent Injective Price Predictions from Analysts

The latest INJ price prediction landscape reveals a divided analyst community. Blockchain.News maintains an optimistic stance with their Injective forecast targeting $6.33 in the short term, despite the recent 12.88% decline. Their medium-term projection extends to $7.50-$9.17, banking on the upcoming Altria upgrade as a catalyst.

However, contrarian views emerge from CoinCheckup’s technical analysis, which suggests a bearish INJ price target of $5.17 by December 21, 2025. This creates an interesting dichotomy where short-term optimism meets medium-term pessimism. CoinMarketCap’s $9.17 prediction relies heavily on the Altria Mainnet Upgrade and potential ETF approvals, while Coinbase’s conservative long-term forecast of $7.14 by 2030 reflects a modest 5% annual growth expectation.

The consensus reveals medium confidence levels across most predictions, indicating uncertainty in the current market environment for Injective.

INJ Technical Analysis: Setting Up for Short-Term Recovery

Current technical indicators paint a mixed but potentially recovering picture for our INJ price prediction. With INJ trading at $5.44, the token sits precariously close to its 52-week low of $5.44, suggesting we may have found a temporary floor.

The RSI reading of 31.18 indicates oversold conditions without reaching extreme levels, providing room for a technical bounce. The MACD histogram at -0.0621 shows bearish momentum is weakening, though not yet reversed. Most compelling is INJ’s position within the Bollinger Bands at 0.0347, placing it near the lower band support at $5.34 – a classic setup for mean reversion toward the middle band at $6.74.

Volume analysis shows $7.25 million in 24-hour trading, which is moderate but sufficient to support a recovery move. The daily ATR of $0.82 suggests we could see significant price swings in either direction, supporting both the bullish $6.33 target and bearish $5.17 scenario.

Injective Price Targets: Bull and Bear Scenarios

Bullish Case for INJ

The primary bullish INJ price target of $6.33 aligns perfectly with technical resistance levels between the current price and the 7-day SMA at $6.10. Breaking above $6.33 would likely trigger momentum toward the 20-day SMA at $6.74, which serves as the critical level for sustained upward movement in our Injective forecast.

If bulls can reclaim the $6.74 level, the next logical target becomes $7.50, representing the middle ground of analyst predictions. The ultimate bullish scenario sees INJ reaching $9.17, contingent on successful implementation of the Altria upgrade and sustained buying pressure above all major moving averages.

Bearish Risk for Injective

The bearish case for our INJ price prediction centers on the failure to hold immediate support at $5.19. A break below this level would likely accelerate selling toward the CoinCheckup target of $5.17, representing a confluence of technical support levels.

The concerning aspect of current Injective technical analysis is the distance from major moving averages – INJ trades 66.44% below its 52-week high and significantly below the 50-day SMA at $8.31. This suggests any recovery attempts may face strong resistance at higher levels.

Should You Buy INJ Now? Entry Strategy

Based on our comprehensive INJ price prediction analysis, the current risk-reward setup favors a tactical approach. For those wondering whether to buy or sell INJ, consider these specific entry strategies:

Conservative Entry: Wait for a break above $5.66 (today’s high) with a stop-loss at $5.19. This approach targets the $6.33 level with a favorable 2:1 risk-reward ratio.

Aggressive Entry: Current levels around $5.44 offer proximity to strong support, but require a tight stop-loss below $5.19 to manage downside risk to the $5.17 target.

Position sizing should remain conservative given the mixed analyst sentiment and the proximity to 52-week lows. The technical setup suggests INJ could move decisively in either direction within the next two weeks.

INJ Price Prediction Conclusion

Our Injective forecast anticipates a near-term recovery to $6.33 within one week, supported by oversold technical conditions and analyst optimism surrounding the Altria upgrade. However, the medium-term outlook remains cautious, with a potential decline to $5.17 by December 21 if broader market conditions deteriorate.

Confidence Level: Medium for the $6.33 target, Medium-Low for the $5.17 bearish scenario.

Key indicators to monitor include the RSI breaking above 35 for bullish confirmation and MACD histogram turning positive. Failure to hold $5.19 support would validate the bearish $5.17 INJ price target. The timeline for this prediction spans the next 4-6 weeks, with the initial recovery phase expected within 7-10 days.

The Altria upgrade remains the wildcard that could invalidate bearish scenarios and propel INJ toward the higher analyst targets of $7.50-$9.17.

Image source: Shutterstock

Source: https://blockchain.news/news/20251122-price-prediction-inj-technical-recovery-to-633-before-december

Market Opportunity
Injective Logo
Injective Price(INJ)
$5,407
$5,407$5,407
+6,77%
USD
Injective (INJ) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Korea Deepens Crypto Push With Tokenized Securities Rules

Korea Deepens Crypto Push With Tokenized Securities Rules

The post Korea Deepens Crypto Push With Tokenized Securities Rules appeared on BitcoinEthereumNews.com. Korea Deepens Crypto Push With Tokenized Securities
Share
BitcoinEthereumNews2026/01/17 16:13
BetFury is at SBC Summit Lisbon 2025: Affiliate Growth in Focus

BetFury is at SBC Summit Lisbon 2025: Affiliate Growth in Focus

The post BetFury is at SBC Summit Lisbon 2025: Affiliate Growth in Focus appeared on BitcoinEthereumNews.com. Press Releases are sponsored content and not a part of Finbold’s editorial content. For a full disclaimer, please . Crypto assets/products can be highly risky. Never invest unless you’re prepared to lose all the money you invest. Curacao, Curacao, September 17th, 2025, Chainwire BetFury steps onto the stage of SBC Summit Lisbon 2025 — one of the key gatherings in the iGaming calendar. From 16 to 18 September, the platform showcases its brand strength, deepens affiliate connections, and outlines its plans for global expansion. BetFury continues to play a role in the evolving crypto and iGaming partnership landscape. BetFury’s Participation at SBC Summit The SBC Summit gathers over 25,000 delegates, including 6,000+ affiliates — the largest concentration of affiliate professionals in iGaming. For BetFury, this isn’t just visibility, it’s a strategic chance to present its Affiliate Program to the right audience. Face-to-face meetings, dedicated networking zones, and affiliate-focused sessions make Lisbon the ideal ground to build new partnerships and strengthen existing ones. BetFury Meets Affiliate Leaders at its Massive Stand BetFury arrives at the summit with a massive stand placed right in the center of the Affiliate zone. Designed as a true meeting hub, the stand combines large LED screens, a sleek interior, and the best coffee at the event — but its core mission goes far beyond style. Here, BetFury’s team welcomes partners and affiliates to discuss tailored collaborations, explore growth opportunities across multiple GEOs, and expand its global Affiliate Program. To make the experience even more engaging, the stand also hosts: Affiliate Lottery — a branded drum filled with exclusive offers and personalized deals for affiliates. Merch Kits — premium giveaways to boost brand recognition and leave visitors with a lasting conference memory. Besides, at SBC Summit Lisbon, attendees have a chance to meet the BetFury team along…
Share
BitcoinEthereumNews2025/09/18 01:20
Trump sues New York Times for $15B, $TRUMP token

Trump sues New York Times for $15B, $TRUMP token

The post Trump sues New York Times for $15B, $TRUMP token appeared on BitcoinEthereumNews.com. Donald Trump sued The New York Times, four of its journalists, and book publisher Penguin Random House for $15 billion in damages in a defamation lawsuit. The lawsuit, filed Monday in a federal court in Florida, alleges their stories intentionally damaged his reputation and one of his major businesses, the $TRUMP cryptocurrency token. In the complaint, Trump charges a sustained attempt by the Times and its reporters to take him down through what he describes as malicious and false reporting. The case identifies a book titled Lucky Loser: How Donald Trump Squandered His Father’s Fortune and Created the Illusion of Success, written by Times reporters Susanne Craig and Russ Buettner. And published by Penguin Random House. Trump’s attorneys contend that the book, as well as accompanying articles questioning his business history and connections between the $TRUMP token and Chinese crypto mogul Justin Sun. Which is unfairly injured both his reputation and his cryptocurrency venture. It responded by rejecting the allegations, referring to the suit as meritless. “This lawsuit has no merit. It has no legitimate legal claims and is instead an effort to discourage and stifle independent reporting,” the paper stated. By promising to keep fighting for press freedom. The legal action comes as the $TRUMP token suffers significant losses. Figures from CoinMarketCap indicate the coin has plunged almost 88% from its all-time high of around $75 to around $8.50. This is giving it a market capitalization of $1.7 billion. Trump maintains that negative news coverage directly contributed to the losses. It is a decline notwithstanding, Trump’s individual fortune has increased due to other crypto-related businesses and investments. Trump’s sons, Eric Trump and Donald Trump Jr.. They have diversified their engagement in blockchain ventures, highlighting the family’s continued thrust into digital assets. Source: https://thenewscrypto.com/trump-sues-new-york-times-for-15b-says-reporting-hurt-trump-token/
Share
BitcoinEthereumNews2025/09/18 13:01